The DOI matches its Crossref record; 428 of the 428 references it cites were found in a registry or an index.
Risk factors and biomarkers of age-related macular degeneration
Open accessAbstract
A biomarker can be a substance or structure measured in body parts, fluids or products that can affect or predict disease incidence. As age-related macular degeneration (AMD) is the leading cause of blindness in the developed world, much research and effort has been invested in the identification of different biomarkers to predict disease incidence, identify at risk individuals, elucidate causative pathophysiological etiologies, guide screening, monitoring and treatment parameters, and predict disease outcomes. To date, a host of genetic, environmental, proteomic, and cellular targets have been identified as both risk factors and potential biomarkers for AMD. Despite this, their use has been confined to research settings and has not yet crossed into the clinical arena. A greater understanding of these factors and their use as potential biomarkers for AMD can guide future research and clinical practice. This article will discuss known risk factors and novel, potential biomarkers of AMD in addition to their application in both academic and clinical settings.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 401–428 of 428
Singh, H. P., Jalali, S., Hejtmancik, J. F., & Kannabiran, C. (2006) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2005.12.009 · Cited by 18
Lü, F., Shi, Y., Qu, C., Zhao, P., Liu, X., Gong, B., Ma, S., Zhou, Y., Zhang, Q., Fei, P., et al. (2013) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.12-11381 · Cited by 18
Differences in the Genetic Susceptibility to Age-Related Macular Degeneration Clinical Subtypes
Shen, L., Hoffmann, T. J., Melles, R. B., Sakoda, L. C., Kvale, M. N., Banda, Y., Schaefer, C. A., RISCH, N. J., & Jorgenson, E. (2015) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.15-16533 · Cited by 18
Complement factor H Val62Ile variant and risk of age-related macular degeneration: a meta-analysis.
Yuan, D., Yang, Q., Liu, X., Yuan, D., Yuan, S., Xie, P., & Liu, Q. (2013) · PubMed Central · Cited by 16
Babanejad, M., Moein, H.-R., Akbari, M. R., Badiei, A., Yaseri, M., Soheilian, M., & Najmabadi, H. (2015) · Ophthalmic Genetics · doi:10.3109/13816810.2014.955585 · Cited by 16
Yu, Q., Yao, Y., Zhu, J., Xin, B., Xie, T., Sun, C., & Cao, J. (2015) · Gene · doi:10.1016/j.gene.2015.02.039 · Cited by 16
Pinna, A., Zinellu, A., TENDAS, D., Blasetti, F., Carru, C., & Castiglia, P. (2015) · Current Eye Research · doi:10.3109/02713683.2014.1002044 · Cited by 16
Quan, Y.-L., Zhou, A., & Feng, Z. (2012) · Europe PMC (PubMed Central) · doi:10.3980/j.issn.2222-3959.2012.02.25 · Cited by 15
Anastasopoulos, E., Kakoulidou, A., Coleman, A. L., Sinsheimer, J. S., Wilson, M. R., Yu, F., Salonikiou, A., Koskosas, A., Pappas, T., Founti, P., et al. (2012) · Current Eye Research · doi:10.3109/02713683.2012.705413 · Cited by 15
Peter, I., & Seddon, J. M. (2010) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2010.06.012 · Cited by 15
Prospective Study of Plasma Homocysteine Level and Risk of Age-Related Macular Degeneration in Women
Christen, W. G., Cook, N. R., Ridker, P. M., & Buring, J. E. (2015) · Ophthalmic Epidemiology · doi:10.3109/09286586.2015.1012272 · Cited by 14
Evaluation of cardiovascular biomarkers in patients with age-related wet macular degeneration
Keleş, S., Kartal, B., Hakan, H., Ekinci, M., Ceylan, E., Öndaş, O., Arpalı, E., Dogan, S., Yıldırım, K., Keleş, M. S., et al. (2014) · Clinical ophthalmology · doi:10.2147/opth.s66160 · Cited by 13
Lack of association of CFD polymorphisms with advanced age-related macular degeneration.
Zeng, J., Chen, Y., Tong, Z., Zhou, X., Zhao, C., Wang, K., Hughes, G., Kasuga, D. T., Bedell, M., Lee, C., et al. (2010) · PubMed Central · Cited by 12
Spencer, K. L., Olson, L. M., Schnetz‐Boutaud, N. C., Gallins, P. J., Wang, G., Scott, W. K., Agarwal, A., Jakobsdóttir, J., Conley, Y. P., Weeks, D. E., et al. (2010) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.09-5112 · Cited by 12
Habibi, I., Sfar, I., Kort, F., Skhiri, H. A., Chebil, A., Chouchene, I., Bouraoui, R., Limaiem, R., Largheche, L., Jendoubi-Ayed, S., et al. (2013) · Ophthalmic Research · doi:10.1159/000345068 · Cited by 12
Cammann, H., Jung, K., Meyer, H., & Stephan, C. (2011) · Clinical Chemistry · doi:10.1373/clinchem.2011.166959 · Cited by 12
CX3CR1 polymorphisms and the risk of age-related macular degeneration.
Ma, B., Dang, G., Yang, S., Duan, L., & Zhang, Y. (2015) · PubMed · Cited by 11
Yasuma, T. R. (2011) · Medical Entomology and Zoology · Cited by 10
Bessho, H., Honda, S., Kondo, N., Kusuhara, S., Tsukahara, Y., & Negi, A. (2012) · PubMed Central · Cited by 9
Kovács, K. A., Pámer, Z., Kovács, A., Fekete, S., Miseta, A., Kovács, B. Á., & Kovács, G. L. (2007) · PubMed · Cited by 9
RAD51 gene is associated with advanced age-related macular degeneration in Chinese population
Zhou, J., Wang, D., Zhang, J., Zhang, M., Lü, F., Qiu, G., Zhao, L., Nguyen, D. H., Luo, H., Cao, G., et al. (2013) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2013.07.002 · Cited by 8
Ye, Z., Shuai, P., Zhai, Y., Li, F., Jiang, L., Lü, F., Wen, F., Huang, L., Zhang, D., Liu, X., et al. (2016) · Scientific Reports · doi:10.1038/srep20914 · Cited by 8
Dong, Y. N., Li, Z.-D., Fang, X., Shi, X., Chen, S., & Tang, X. (2015) · International Journal of Ophthalmology · doi:10.3980/j.issn.2222-3959.2015.02.31 · Cited by 6
Clinically detectable drusen domains in fibulin-5-associated age-related macular degeneration (AMD)
Küçükevcilioğlu, M., Patel, C. B., Stone, E. M., & Russell, S. R. (2015) · International Ophthalmology · doi:10.1007/s10792-015-0164-5 · Cited by 6
Wickremasinghe, S., Sandhu, S. S., Islam, A. F. M., Abedi, F., Richardson, A. J., Baird, P. N., & Guymer, R. H. (2014) · Retina · doi:10.1097/iae.0000000000000258 · Cited by 5
Wong, C. W., Liao, J., Cheung, C. M. G., Khor, C. C., Vithana, E. N., Wang, J. J., Mitchell, P., Aung, T., Wong, T. Y., & Cheng, C. (2015) · PLoS ONE · doi:10.1371/journal.pone.0119570 · Cited by 4
Hagbi-Levi, S., Grunin, M. A., Elbaz-Hayoun, S., Tal, D., Obolensky, A., Hanhart, J., Banin, E., Burstyn‐Cohen, T., & Chowers, I. (2015) · Ophthalmic Research · doi:10.1159/000441794 · Cited by 3
Netrin-1 – DCC Signaling Systems and Age-Related Macular Degeneration
SanGiovanni, J. P., Chen, J., Gupta, A. S., Smith, L. E. H., Sapieha, P. S., & Lee, P. H. (2015) · PLoS ONE · doi:10.1371/journal.pone.0125548 · Cited by 2
Cited by
Age-related macular degeneration
Mitchell, P., Liew, G., Gopinath, B., & Wong, T. Y. (2018) · The Lancet · doi:10.1016/s0140-6736(18)31550-2 · Cited by 1,511
Endoplasmic reticulum stress: molecular mechanism and therapeutic targets
Chen, X., Shi, C., He, M., Xiong, S., & Xia, X. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01570-w · Cited by 1,007
Pennington, K. L., & DeAngelis, M. M. (2016) · Eye and Vision · doi:10.1186/s40662-016-0063-5 · Cited by 480
The blood–retina barrier in health and disease
O’Leary, F., & Campbell, M. (2023) · The FEBS Journal · doi:10.1111/febs.16330 · Cited by 334
Rowan, S., Jiang, S., Korem, T., Szymanski, J., Chang, M.-L., Szelog, J., Cassalman, C., Dasuri, K., McGuire, C., Nagai, R., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1702302114 · Cited by 272
Metadata
- Authors
- Lambert, N. G., ElShelmani, H., Singh, M. K., Mansergh, F. C., Wride, M. A., Padilla, M., Keegan, D., Hogg, R. E., & Ambati, B. K.
- Venue
- Progress in Retinal and Eye Research
- Publisher
- Elsevier BV
- Published
- 2016-09
- Volume
- 54
- Pages
- 64-102
- ISSN
- 1350-9462 (ISSN-L)
- OpenAlex
- W2347205644
- Cited by
- 351
- References
- 428
- FWCI
- 27.65
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.